![]() |
CrossRef Text and Data Mining |
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining. |
Olaratumab and doxorubicin for the treatment of metastatic soft tissue sarcoma: a retrospective case series |
Joon Young Hur, Se Hoon Park, Su Jin Lee |
Precis Future Med. 2019;3(2):77-84. Published online May 30, 2019 DOI: https://doi.org/10.23838/pfm.2019.00016 |
Olaratumab and doxorubicin for the treatment of metastatic soft tissue sarcoma: a retrospective case series A pilot study of first-line olaratumab, doxorubicin and ifosfamide in patients with metastatic soft tissue sarcoma Combination therapy with Olaratumab/doxorubicin in advanced or metastatic soft tissue sarcoma -a single-Centre experience Outcome for Advanced or Metastatic Soft Tissue Sarcoma of Nonextremities Treated with Doxorubicin-Based Chemotherapy: A Retrospective Study from a Single Cancer Institution Olaratumab combined with doxorubicin and ifosfamide overcomes individual doxorubicin and olaratumab resistance of an undifferentiated soft-tissue sarcoma in a PDOX mouse model Real-world experience of Olaratumab and Doxorubicin versus Doxorubicin alone for advanced soft-tissue sarcoma in a UK centre Treatment of Adult Metastatic Soft-Tissue Sarcoma with Doxorubicin/ Ifosfamide: Better Hematologic Tolerance by G-CSF? Cost-Effectiveness of Olaratumab in Combination with Doxorubicin for Patients with Soft Tissue Sarcoma in the United States Spotlight on olaratumab in the treatment of soft-tissue sarcoma: design, development, and place in therapy Doxorubicin-Based Chemotherapy for the Palliative Treatment of Adult Patients with Locally Advanced or Metastatic Soft-Tissue Sarcoma: A Meta-Analysis and Clinical Practice Guideline |